Ratings Trulieve Cannabis Corp. OTC Markets

Equities

TCNNF

CA89788C1041

Delayed OTC Markets Other stock markets 09:46:16 2024-04-23 am EDT			5-day change	1st Jan Change
10.82 ^USD	+2.08%		+1.12%	+107.68%

Apr. 22	Trulieve Cannabis Brief: Opening Medical Cannabis Dispensary in North Palm Beach, Florida	MT
Apr. 02	Pot producers climb as recreational cannabis to go on Florida ballot	RE

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
The company has a low valuation given the cash flows generated by its activity.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For several months, analysts have been revising their EPS estimates roughly upwards.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
The opinion of analysts covering the stock has improved over the past four months.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
Low profitability weakens the company.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Pharmaceuticals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
TRULIEVE CANNABIS CORP.	+107.68%	2.02B		-
CURALEAF HOLDINGS, INC.	+21.42%	3.56B		C-
GOODNESS GROWTH HOLDINGS, INC.	+80.95%	59.43M	-	-
ACREAGE HOLDINGS, INC.	+265.38%	54.09M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes